期刊文献+

糖基化磷脂酰肌醇磷脂酶D与动脉粥样硬化关系的研究 被引量:2

Study of the effect of glycosylphosphatidylinositol-specific phospholipase D on atherosclerosis
原文传递
导出
摘要 目的探讨糖基化磷脂酰肌醇特异性磷脂酶D(GPI—PLD)在动脉粥样硬化病理生理过程中的作用及其机制。方法分别收集102例冠心病患者和121例健康者外周血,测定其外周血GPI-PLD酶活性及其单个核细胞GPI—PLDmRNA表达。构建高表达GPI—PLD基因HUVEC细胞模型,并设立空白组和对照组,进行omLDL诱导,观察各组内皮细胞功能及生物学特性的改变。结果冠心病患者和健康者其外周血GPI—PLD酶活性分别为31.80±4.21和44.32±4.50,单个核细胞GPI—PI,DmRNA表达比值分别是0.92±0.16和1.53±0.14;冠心病患者组外周血GPI—PLD酶活性(t=21.31,P〈0.01)及其mRNA表达(t=30.36,P〈0.01),较健康者组分别减少28.2%和39.9%。ox-LDL诱导的各组细胞,高表达GPI-PLD细胞模型组细胞表面黏附单核细胞数、内皮素1、活性氧、丙二醛及凋亡率均低于空白组[29.59±1.40、3.51±0.45、(50.63±4.22)ng/L、0043±0.011、(3.32±0.44)nmol/L比41.39±2.15、10.57±1.12、(59.35±4.45)ng/L、0.052±0.011、(5.01±0.69)nmol/L3和对照组[42.68±2.45、9.92±1.03、(61.11±4.12)ng/L、0051±0.007、(4.89±0.71)nmol/L],而一氧化氮含量高于空白组[(29.88±1.37μmol/L比(21.76±1.02)μmol/L]和对照组(23.43±0.85)μmol/L。结论GPI-PLD基因在冠心病患者中低表达,稳定高表达GPI—PLD有助于血管内皮细胞损伤的修复,有助于阻止动脉粥样硬化的发生和发展。 Objective To investigate the effect of glycosylphosphatidylinositol specific phospholipase D (GPI-PLD) on artherosclerosis. Methods The GPI-PLD activities and mononuclear cells GPI-PLD gene mRNA expression was detected in 102 patients with coronary artery disease and 121 healthy adult. The GPI-PLD highly expressing cell model was constructed and induced by ox-LDL, the HUVEC and HUVEC transfected with pcDNA3.1 (+) as blank and control group, respectively. Before and after the induction, the change of cellular function and biological features was detected. Results The peripheral blood GPI-PLD activity of patients with coronary heart disease and normal control were 31.80 ± 4.21 and 44.32 ± 4.50, and the IA ratio of GPbPI.D mRNA expression of mononuclear cells were 0.92 ±0. 16 and 1. 53± 0.14, respectively. The activity of GPI PLD and mRNA expression in patients with coronary artery disease were decreased up to 28.2% (t= 21.31, P〈0.01) and 39.9% (t=30.36, P〈0.01) as compared with healthy control. The adhesion cells, ET-1, reactive oxygen, malondialdehyde (MDA) and the apoptosis rate of GPI-PLD overexpressing HUVEC were lower as compared with blank [29.59 ± 1.40, 3.51± 0.45, (50.63 ±4.22) ng/L, 0.043±0.011, (3.32±0.44) nmol/Lvs. 41.39vs2.15, 10.57±1.12, (59.35±4.45) ng/L, 0. 052±0. 011, (5. 01±0.69) nmol/L3, and as compared with control (42. 68±2.45, 9.92±1.03,(61.11±4.12) ng/L, 0. 051±0. 007, (4. 89±0.71) nmol/L] after inducing by ox-LDL; while the level of nitrogen noxidium (NO) was higher than blank [(29. 88± 1.37)μmol/L. vs. (21. 76±1.02)μmol/L. and control(23.43±0.85)μmol/L groups of GPI-PLD in patients with coronary artery disease are expression of GPI-PLD is beneficial to vascular endothelial occurrence and development of atherosclerosis. Conclusions The expression and activity lower than health people. Stable high ceil injury repairment and prevent the occurrence and development of atherosclerosis.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2012年第11期954-958,共5页 Chinese Journal of Geriatrics
基金 国家自然科学基金(39970315,30271456)
关键词 磷脂酶类 内皮 血管 动脉粥样硬化 Phospholipases Endotheiium, vascular Atherosclerosis
  • 相关文献

参考文献17

  • 1Raikwar NS, Cho WK, Bowen RF, et al. Glycosylphosphati-dylinosito 1-specific phospholipase D influences triglyceride-rich lipoprotein metabolism. Am J Physiol Endocrinol Metab, 2006 ,290 :463-470.
  • 2Raikwar NS,Bowen-Deeg RF, Du XS, et al. Glycosylphosphati-dylinositol-vspecific phospholipase D improves glucose tolerance. Metabolism,2010,59: 1413-1420.
  • 3Gray DL,0,Brien KD,Df Alessio DA,et al. Plasma glycosylphosphati-dylinositol-specific phospholipaseD predicts the change in insulin sensitivity in response to a low-fat but not a low-carbohydrate diet in obese women. Metabolism, 2008,57 :473-478.
  • 4唐建华,李文凯.血清糖基化磷脂酰肌醇特异性磷脂酶D的检测[J].湖南医科大学学报,1999,24(2):119-122. 被引量:17
  • 5Kiyan J,Smith G,Haller H,et al. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts. Biochem J,2009 ,423 : 343-351.
  • 6Hsu WY, Chao YW,Tsai YL, et al. Resistin induces monocyte-endothelial cell adhesion by increasing ICAM-1 and VCAM-1 expression in endothelial cells via p38MAPK-dependent pathway. J Cell Physiol, 2011,226:2181-2188.
  • 7Ivanov D,Philippova M, Antropova J, et al. Expression of cell adhesion molecule T-cadherin in the human vasculature. Histochem Cell Biol, 2001, 115: 231-242.
  • 8Hazenbos WL4 Murakami Y,Nishimura J, et al. Enhanced responses of glycosylphosphatidylinosi to! anchor-deficient T lymphocytes. J Immunol, 2004, 173: 3810-3815.
  • 9Davignon J,Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation, 2004 ,109 : 27-32.
  • 10郑成环,王林,周长钰,李广平,杨丽秀,陈新.老年冠心病患者血管内皮功能与动脉粥样硬化的关系[J].中华老年医学杂志,2010,29(3):212-214. 被引量:8

二级参考文献49

  • 1余明琨,龚隽.糖基磷脂酰肌醇专一的磷脂酶D[J].生命的化学,1996,16(4):30-32. 被引量:1
  • 2杜瑞雪,范利,李小鹰,韦立新,韩志涛,胡亚卓.尸检老年患者冠状动脉粥样硬化与外周动脉粥样硬化的相关性[J].中国临床康复,2006,10(40):46-48. 被引量:12
  • 3Superko HR. Beyond LDL cholesterol reduction. Circulation, 1996,94 : 2351-2354.
  • 4Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome:importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab,2004,89:2601-2607.
  • 5Wyatt SB,Winters KP,Duhbert PM. Overweight and obesity., prevalence, consequences, and causes of a growing public health problem. Am J Med Sci,2006, 331:166-174.
  • 6Palmieri I.,Trojani M, Vanuzzo D,et al. Distribution of the global cardiovascular risk in the Italian population : results from the cardiovascular epidemiologic observatory. Ital Heart J Suppl, 2005, 6:279-284.
  • 7Grundy S, Cleernar JI, Noel BM, et al. Implication of recent clinical trails for the national cholesterol education program adult treatment panel Ⅲ guideliness. Circulation, 2004,110 : 227-239.
  • 8Virella G, Atchley D, Koskinen S, et al. Proatherogenie and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL. Clin Immuno, 2002,105:81-92.
  • 9Brunzell JD. Increased ApoB in small dense LDL particles predicts premature coronary artery disease, arterioscler, Thromb. Vasc. Biol, 2005, 25 :474-475.
  • 10Wang JJ,Qiang HJ, Zhang CN, et al. Detection of IgG bound lipoprotein (a) immune complexes in patients with coronary heart disease. Clin Chem Acta, 2003,327:115-122.

共引文献25

同被引文献17

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部